This study suggests that trust in hospitalized medicine patients is not influenced by whether their physicians wear white coats or surgical scrubs. Clinical competence, communication, and interpersonal warmth matter more than physician attire. Dr. Cary is an academic hospitalist at Erlanger Hospital and program director of the internal medicine residency program and associate professor of… Read More
In a multicenter cohort of patients hospitalized for CHF exacerbation, a higher-than-home initial diuretic dose was associated with shorter LOS and higher risk of acute kidney injury, with no change in mortality. These findings suggest that initial diuretic dosing plays an important role in determining clinical outcomes for acute HF. Dr. Smith is an academic… Read More
In patients with AF, CAD, and advanced CKD, OAC monotherapy is at least as effective as dual antithrombotic therapy and is likely safer. Dr. Pumilia practices outpatient general internal medicine at Erlanger Hospital and is an assistant professor of medicine at University of Tennessee Health Science Center College of Medicine, both in Chattanooga, Tenn.
Discontinuation of SGLT2 inhibitors after developing UTI is associated with increased risk of cardiovascular and renal outcomes and overall increased mortality and does not decrease risk of recurrent UTIs. Dr. Tudor is an academic hospitalist at Erlanger Hospital and associate program director of the internal medicine residency program and associate professor of medicine at the… Read More
Among patients with AF treated with apixaban or rivaroxaban, concomitant use of diltiazem was associated with a small but statistically significant absolute increase in the risk for serious bleeding compared with metoprolol, without a meaningful difference in stroke or systemic embolism. Clinicians should consider this potential drug interaction, particularly when prescribing higher doses of diltiazem.… Read More
Long-term PPI use is associated with increased exacerbation risk in chronic obstructive airway disease; short courses for clear indications appear safe. Dr. Herring is a PGY-2 internal medicine resident at the University of Tennessee Health Sciences College of Medicine and Erlanger Hospital, both in Chattanooga, Tenn.
HI-PEITHO is the first large RCT to demonstrate clinical benefit from advanced therapy in this population. USCDT significantly reduced a composite outcome driven largely by early physiologic deterioration, with a reassuring bleeding profile. Dr. Smith is an academic hospitalist at Erlanger Hospital and division chief of general internal medicine and assistant professor of medicine at… Read More
Once-weekly semaglutide reduces heavy drinking days and total alcohol consumption in treatment-seeking patients with alcohol use disorder and comorbid obesity. Dr. Lubin is a PGY-3 internal medicine resident at the University of Tennessee Health Sciences College of Medicine and Erlanger Hospital, both in Chattanooga, Tenn.
